1 Min Read
LONDON, Dec 18 (Reuters) - GlaxoSmithKline Plc : * GSK and Theravance announce regulatory submission for umec/vi (lama/laba) in
the US * Regulatory filings for umec/vi are planned in the EU imminently and in other
countries during the course of 2013
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.